Package 50090-5245-0
Brand: bupropion hydrochloride
Generic: bupropion hydrochloridePackage Facts
Identity
Package NDC
50090-5245-0
Digits Only
5009052450
Product NDC
50090-5245
Description
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5245-0)
Marketing
Marketing Status
Brand
bupropion hydrochloride
Generic
bupropion hydrochloride
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "276e4e7b-c793-46ae-b05c-9b268b236b6b", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["a18b5460-fcbb-42dd-8b87-197d11a08928"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5245-0)", "package_ndc": "50090-5245-0", "marketing_start_date": "20201012"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5245-1)", "package_ndc": "50090-5245-1", "marketing_start_date": "20201012"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "50090-5245_276e4e7b-c793-46ae-b05c-9b268b236b6b", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-5245", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20190325", "listing_expiration_date": "20261231"}